Informa Life Sciences conference: Veterinary Medicines: Generics, Patents and Parallel Imports Summit
Taylor Wessing associate, Tim Worden, will be speaking on the second day of this conference
Tim Worden will be speaking on "The EU Bolar Provision", and will examine:
- Implementation of the provision
- What does it permit: stockpiling, support for foreign filing, validation runs?
- National differences in scope across the EU
- Implications of these differences to generic product manufacturers and studies
- Lessons to be learnt from the US
If you would like to know more about any of these issues,
please contact Tim Worden.
About the conference
The conference is designed to help companies in developing cost effective strategies to meet regulatory requirements and decrease time to market for their products. It includes practical regulatory advice from seven national regulators, as business and regulator insights from across the industry. For more information on the conference, please click here.
About Taylor Wessing's Life Sciences & Healthcare Group
Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service. The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices. We advise life sciences and healthcare businesses, those who fund them and those who work for them.
For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.
For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing. For any marketing and business development enquiries, please contact Sharon Philbey.
03.07.2007 - 04.07.2007
The Hilton Hotel, Amsterdam, The Netherlands